Quick answer
Bristol-Myers Squibb Company (BMY) reported diluted EPS of $1.62 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-30. Its last four 10-Q/10-K filings were on 2026-07-30, 2026-04-30, 2026-02-11, 2025-10-30.
Data as of 2026-07-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-07-30 | $1.62 |
| 2026-03-31 | Quarter | 10-Q | 2026-04-30 | $1.31 |
| 2025-12-31 | Full year | 10-K | 2026-02-11 | $3.46 |
| 2025-09-30 | Quarter | 10-Q | 2025-10-30 | $1.08 |
| 2025-06-30 | Quarter | 10-Q | 2025-07-31 | $0.64 |
| 2025-03-31 | Quarter | 10-Q | 2025-04-24 | $1.20 |
| 2024-12-31 | Full year | 10-K | 2025-02-12 | $-4.41 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $0.60 |
| 2024-06-30 | Quarter | 10-Q | 2024-07-26 | $0.83 |
| 2024-03-31 | Quarter | 10-Q | 2024-04-25 | $-5.89 |
| 2023-12-31 | Full year | 10-K | 2024-02-13 | $3.86 |
| 2023-09-30 | Quarter | 10-Q | 2023-10-26 | $0.93 |
| 2023-06-30 | Quarter | 10-Q | 2023-07-27 | $0.99 |
| 2023-03-31 | Quarter | 10-Q | 2023-04-27 | $1.07 |
| 2022-12-31 | Full year | 10-K | 2023-02-14 | $2.95 |
| 2022-09-30 | Quarter | 10-Q | 2022-10-26 | $0.75 |
Related
- BLK earnings report dates and EPS history (BlackRock, Inc.)
- BMNR earnings report dates and EPS history (Bitmine Immersion Technologies, Inc.)
- BMRN earnings report dates and EPS history (Biomarin Pharmaceutical Inc)
- BNY earnings report dates and EPS history (Bank of New York Mellon Corp)
- BPOP earnings report dates and EPS history (Popular, Inc.)
- BR earnings report dates and EPS history (Broadridge Financial Solutions, Inc.)
- BRKR earnings report dates and EPS history (Bruker Corporation)
- BRO earnings report dates and EPS history (Brown & Brown, Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.